Acelyrin adopts poison pill as Tang Capital Partners raises stake
Acelyrin (NASDAQ:SLRN) stock in focus as the company adopts a poison pill to counter rapid stock acquisition by Tang Capital Partners. Read more here.
Acelyrin: Potential Buyout Led By Concentra Biosciences
Concentra Biosciences offers $3/share + CVR for Acelyrin, outperforming Alumis' bid. Read why I rate SLRN stock a Sell at ...
Alumis Inc. (ALMS) Receives a Buy from H.C. Wainwright
In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price ...
Alumis (NASDAQ:ALMS) Earns Buy Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of Alumis (NASDAQ:ALMS – Free Report) in a report published on Monday,Benzinga reports. They currently have a $19.00 price objective on the stock. A ...
WLFI News 182d
Cuts to US foreign aid are hurting efforts to tackle human trafficking at scam compounds. Americans may pay the price
It wasn’t long after landing in Bangkok, Thailand, in the summer of 2023 that Jalil Muyeke realized that something was ...
Automotive Rhythms3d
BMW Celebrates 50 Years of the Venerable 3 Series
Experienced by Kimatni D. Rawlins It’s a celebratory year as BMW pays homage to 50 years of the well-respected 3 Series in ...
Alumis Inc. (ALMS) Receives a Buy from Oppenheimer
In a report released today, Jeff Jones from Oppenheimer reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price target of ...